{"id":3254,"date":"2023-12-05T01:55:20","date_gmt":"2023-12-05T01:55:20","guid":{"rendered":"http:\/\/drhimanshuyadav.com\/lunit-releases-clinical-study-results-offering-insight-into-colon-cancer-prognosis\/"},"modified":"2023-12-05T01:55:20","modified_gmt":"2023-12-05T01:55:20","slug":"lunit-releases-clinical-study-results-offering-insight-into-colon-cancer-prognosis","status":"publish","type":"post","link":"https:\/\/drhimanshuyadav.com\/blog\/lunit-releases-clinical-study-results-offering-insight-into-colon-cancer-prognosis\/","title":{"rendered":"Lunit releases clinical study results offering insight into colon cancer prognosis"},"content":{"rendered":"<div id=\"content-body-15659354\">\n<p class=\"WordDefaultStyle\"><span class=\"Hyperlink0\">runit<\/span>  reported results from a Korean clinical study showing how its Lunit SCOPE IO tissue analysis software helped predict prognosis for patients with stage II-III colon cancer treated with curative surgery and adjuvant therapy. did.<\/p>\n<p class=\"WordDefaultStyle\">Lunit SCOPE IO is a deep learning-based tumor-infiltrating lymphocyte (TIL) analyzer consisting of two complementary learning models developed for cell detection and tissue segmentation. It analyzes the tumor microenvironment based on hematoxylin and eosin analysis, a common testing technique used in research to provide a detailed view of tissue architecture, and provides AI-based predictive clinical outcome information. Masu. <\/p>\n<p class=\"WordDefaultStyle\">of  <a href=\"https:\/\/doi.org\/10.1038\/s41698-023-00470-0\" target=\"_blank\" rel=\"noopener\">retrospective study<\/a>was announced in <em>NPJ Precision Oncology<\/em>, conducted by researchers from Seoul National University Bundang Hospital, Seoul National University of Medicine, and Lunit. Researchers evaluated the clinical utility of AI-based spatial TIL analysis for predicting post-treatment prognosis in 289 patients with stage II-III colon cancer. <\/p>\n<p class=\"WordDefaultStyle\">Patients with confirmed recurrence showed significantly lower interstitial TIL density compared to patients without recurrence. The study also clearly identified high-, intermediate-, and low-risk groups. These groups predicted recurrence-free survival and were independently associated with clinical outcomes after adjusting for other clinical factors.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>runit reported results from a Korean clinical study showing how its Lunit SCOPE IO tissue analysis software helped predict prognosis for patients with stage II-III colon cancer treated with curative surgery and adjuvant therapy. did. Lunit SCOPE IO is a deep learning-based tumor-infiltrating lymphocyte (TIL) analyzer consisting of two complementary learning models developed for cell &#8230; <a title=\"Lunit releases clinical study results offering insight into colon cancer prognosis\" class=\"read-more\" href=\"https:\/\/drhimanshuyadav.com\/blog\/lunit-releases-clinical-study-results-offering-insight-into-colon-cancer-prognosis\/\" aria-label=\"Read more about Lunit releases clinical study results offering insight into colon cancer prognosis\">Read more<\/a><\/p>\n","protected":false},"author":2,"featured_media":3255,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[3,431,4,2163,2164,2165,829,2166,440,342],"class_list":["post-3254","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-colorectal-cancer","tag-cancer","tag-clinical","tag-colon","tag-insight","tag-lunit","tag-offering","tag-prognosis","tag-releases","tag-results","tag-study"],"_links":{"self":[{"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/posts\/3254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/comments?post=3254"}],"version-history":[{"count":0,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/posts\/3254\/revisions"}],"wp:attachment":[{"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/media?parent=3254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/categories?post=3254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drhimanshuyadav.com\/blog\/wp-json\/wp\/v2\/tags?post=3254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}